Contact and place of performance
Andrew L Taylor
Not specified
Statement of Need The Corporal Michael J. Crescenz VA Medical Center s (CMCVAMC) Nuclear Medicine department requires a licensed vendor by the Nuclear Regulatory Commission to provide the radiopharmaceutical drug Axumin (fluciclovine F 18 Injection) and calibration sources. This radiopharmaceutical drug is required for a new imaging procedure that will be offered to Veterans. The Calibration sources are required for...
View moreThe Department of Veterans Affairs is soliciting bids under solicitation number 36C24421Q0627 for the procurement of Axumin (fluciclovine F 18 Injection) and necessary calibration sources. This radiopharmaceutical drug is required by the Nuclear Medicine department at the Corporal Michael J. Crescenz VA Medical Center (CMCVAMC) in Philadelphia, Pennsylvania, for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence. The requirement includes the delivery of unit doses directly to the medical center’s secured receiving area to support new imaging procedures and equipment quality control testing. The acquisition is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, DRUGS AND BIOLOGICALS.
The selected vendor, which must be licensed by the Nuclear Regulatory Commission, is responsible for providing an adequate supply of contract products labeled with preparation and expiration details compatible with the facility's nuclear medicine information management system. Performance involves routine daily deliveries, same-day delivery within two hours of an order during business hours, and emergency deliveries within a 45-minute window. The contractor is also required to manage radiopharmaceutical returns for credit, provide electronic dose tracking systems, and ensure all packaging complies with federal and state regulations for radioactive materials.
Administrative requirements include monthly itemized invoicing and technical support or training if the vendor’s data system differs from the medical center's current software. Orders will be placed by authorized CMCVAMC personnel via telephone, fax, or email on an as-needed basis. The response deadline for this solicitation is June 11, 2021. Point of contact for the notice is Andrew L. Taylor, and the solicitation includes two attachments: a Word document detailing the solicitation and a redacted Justification and Approval for other than full and open competition.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.